Upstream Bio Market Cap 1971-1970 | UPB

Upstream Bio market cap as of October 22, 2024 is $1.33B.

Upstream Bio market cap history and chart from 1971 to 1970. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Upstream Bio Market Cap 1971-1970 | UPB

Upstream Bio market cap history and chart from 1971 to 1970. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$172.8B
Vertex Pharmaceuticals (VRTX)$124.7B
Regeneron Pharmaceuticals (REGN)$109.2B
Gilead Sciences (GILD)$108B
Bristol Myers Squibb (BMY)$107.9B
CSL (CSLLY)$97.9B
GSK (GSK)$79.9B
Alnylam Pharmaceuticals (ALNY)$38B
Argenex SE (ARGX)$33.8B
Biogen (BIIB)$27.7B
BioNTech SE (BNTX)$26.6B
Illumina (ILMN)$23.3B
BeiGene (BGNE)$21.3B
Moderna (MRNA)$20.8B
Genmab (GMAB)$15.2B
BioMarin Pharmaceutical (BMRN)$13.3B
Exact Sciences (EXAS)$13.3B
Vaxcyte (PCVX)$12.9B
Insmed (INSM)$12.8B
Incyte (INCY)$12.8B
Sarepta Therapeutics (SRPT)$12.1B
Bio-Techne Corp (TECH)$11.3B
QIAGEN (QGEN)$9.8B
Bio-Rad Laboratories (BIO.B)$9.3B
Roivant Sciences (ROIV)$8.8B
Revolution Medicines (RVMD)$8.4B
Intra-Cellular Therapies (ITCI)$8.3B
Exelixis (EXEL)$8.2B
Repligen (RGEN)$8.2B
Ascendis Pharma (ASND)$7.9B